Cargando…

Mutation-profile-based methods for understanding selection forces in cancer somatic mutations: a comparative analysis

Human genes exhibit different effects on fitness in cancer and normal cells. Here, we present an evolutionary approach to measure the selection pressure on human genes, using the well-known ratio of the nonsynonymous to synonymous substitution rate in both cancer genomes (C(N)/C(S)) and normal popul...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhan, Zou, Yangyun, Liu, Gangbiao, Zhou, Jingqi, Wu, Jingcheng, Zhao, Shimin, Su, Zhixi, Gu, Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601697/
https://www.ncbi.nlm.nih.gov/pubmed/28938601
http://dx.doi.org/10.18632/oncotarget.19371
Descripción
Sumario:Human genes exhibit different effects on fitness in cancer and normal cells. Here, we present an evolutionary approach to measure the selection pressure on human genes, using the well-known ratio of the nonsynonymous to synonymous substitution rate in both cancer genomes (C(N)/C(S)) and normal populations (p(N)/p(S)). A new mutation-profile-based method that adopts sample-specific mutation rate profiles instead of conventional substitution models was developed. We found that cancer-specific selection pressure is quite different from the selection pressure at the species and population levels. Both the relaxation of purifying selection on passenger mutations and the positive selection of driver mutations may contribute to the increased C(N)/C(S) values of human genes in cancer genomes compared with the p(N)/p(S) values in human populations. The C(N)/C(S) values also contribute to the improved classification of cancer genes and a better understanding of the onco-functionalization of cancer genes during oncogenesis. The use of our computational pipeline to identify cancer-specific positively and negatively selected genes may provide useful information for understanding the evolution of cancers and identifying possible targets for therapeutic intervention.